SafeRx Pharmaceuticals Inc.

CIK: 1850523DEIncorporated: 2021-05-10

Current Offering

$25,000
Target Amount
$5,000,000
Maximum Amount
2022-04-30
Deadline

Security Details

Type: Common Stock
Price per share: $2.21
Shares offered: 2,262,443+

Offering Costs

Cash commission: 4%
4% of all sums raised in this offering (1% of which will be delivered in Class B Non-Voting Common Stock), plus a $25,000 fee.
Equity compensation: 1%
Dalmore Group LLC will receive the company's Class B Non-Voting Common Stock equal to 1% of aggregate amount raised.

Financial Reports

Offering via

Offering History

As of 2021-05-25
Raising $25,000 -$5,000,000 via 2,262,443+ shares of common Stock at $2.21 per share
Deadline: 2022-04-30
Filing date2021-05-25
Current employees2
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$175,149
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$822,403.00
Net income prior fiscal year$0.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$817,551
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$175,149
Total asset prior fiscal year$0.00

Company Information

Corporation
DE
2021-05-10

Latest Metrics

Employees2
Total Assets$175,149
Cash on Hand$175,149
Revenues$0.00
Net Income-$822,403.00

Crowdfunding Portals

This company is raising funds through this portal